932PHyperphosphatemia due to erdafitinib (a pan-FGFR...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

932PHyperphosphatemia due to erdafitinib (a pan-FGFR Inhibitor) and anti-tumour activity among patients (Pts) with advanced urothelial carcinoma (UC)

Tagawa, S, Siefker-Radtke, A, Dosne, A -G, Zhong, B, Qi, K, Shalaby, W, O’Hagan, A, De Porre, P, Mahadevia, P, Loriot, Y
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.031
Date:
October, 2019
File:
PDF, 79 KB
english, 2019
Conversion to is in progress
Conversion to is failed